Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’

Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’

Bibliographic Details
Main Authors: Assad Shiti, Idit Goldfracht, Naim Shaheen, Stephanie Protze, Lior Gepstein
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-21950-6
id doaj-419b4694c7dd4aeca6ebb99f29e4bade
record_format Article
spelling doaj-419b4694c7dd4aeca6ebb99f29e4bade2021-03-21T12:14:06ZengNature Publishing GroupNature Communications2041-17232021-03-011211310.1038/s41467-021-21950-6Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’Assad Shiti0Idit Goldfracht1Naim Shaheen2Stephanie Protze3Lior Gepstein4Sohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion‒Israel Institute of TechnologySohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion‒Israel Institute of TechnologySohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion‒Israel Institute of TechnologyMcEwen Center for Regenerative Medicine, University Health NetworkSohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion‒Israel Institute of Technologyhttps://doi.org/10.1038/s41467-021-21950-6
collection DOAJ
language English
format Article
sources DOAJ
author Assad Shiti
Idit Goldfracht
Naim Shaheen
Stephanie Protze
Lior Gepstein
spellingShingle Assad Shiti
Idit Goldfracht
Naim Shaheen
Stephanie Protze
Lior Gepstein
Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
Nature Communications
author_facet Assad Shiti
Idit Goldfracht
Naim Shaheen
Stephanie Protze
Lior Gepstein
author_sort Assad Shiti
title Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title_short Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title_full Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title_fullStr Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title_full_unstemmed Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title_sort reply to ‘are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2021-03-01
url https://doi.org/10.1038/s41467-021-21950-6
work_keys_str_mv AT assadshiti replytoareatrialhumanpluripotentstemcellderivedcardiomyocytesreadytoidentifydrugsthatbeatatrialfibrillation
AT iditgoldfracht replytoareatrialhumanpluripotentstemcellderivedcardiomyocytesreadytoidentifydrugsthatbeatatrialfibrillation
AT naimshaheen replytoareatrialhumanpluripotentstemcellderivedcardiomyocytesreadytoidentifydrugsthatbeatatrialfibrillation
AT stephanieprotze replytoareatrialhumanpluripotentstemcellderivedcardiomyocytesreadytoidentifydrugsthatbeatatrialfibrillation
AT liorgepstein replytoareatrialhumanpluripotentstemcellderivedcardiomyocytesreadytoidentifydrugsthatbeatatrialfibrillation
_version_ 1724210734002339840

Similar Items